Macrophage exclusive chimeric antigen receptor, controllable polarized mononuclear/macrophage for expressing macrophage exclusive chimeric antigen receptor and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2021-09-17
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to a macrophage-specific chimeric antigen receptor, a controllable polarized monocyte / macrophage expressing the receptor, and a preparation method and application thereof. Background technique
[0002] Glioblastoma (GBM), thought to arise from glial progenitor cells, is the most prevalent and aggressive primary brain tumor ever discovered. Its incidence accounts for 12%-15% of intracranial tumors and 50%-60% of astrocytic tumors. The median survival of patients with this tumor is about 15 months, and the 5-year survival rate is less than 10%. Therefore, this tumor poses a great threat to human life and health. Although the current treatment methods for GBM include surgery, radiotherapy, and chemotherapy, but because the tumor infiltrates and grows deep into the brain lobe, and has the characteristics of rapid growth and easy recurrence, the effect is minimal and it is easy to cause di...